New Rochelle, NY, March 19, 2019—A new study shows that inhaled doses of as little as 2 mg of the synthetic cannabinoid JWH-018 can significantly impair critical thinking and memory, slow reaction times, and increase confusion and dissociation. The results of this placebo controlled, cross-over study are published in Cannabis and Cannabinoid Research, a peer-reviewed… Continue reading Even Low Doses of Synthetic Cannabinoids Can Impair Cognitive Performance
New research from our group provides more evidence that psilocybin, the active ingredient in magic mushrooms, can improve creative thinking, empathy, and subjective well-being. Read more here, here ,and here.
07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast here (scroll to 1 hr 51 min)
Malin Uthaug, PhD student in our department, recently discussed the ethical considerations of inhaling bufotoxins from Incilius Alvarius. Read her opinions on this practice here
Kim Kuypers spoke with NPO Radio 1, about LSD, microdosing, and our ongoing microdosing trial. Listen to the podcast here.